Global Strategic Investment Solutions’s Eli Lilly LLY Stock Holding History

Global Strategic Investment Solutions’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$392K	Sell	327 -3	-0.9%	-$3.06K	0.03%	115
2026 Q1	$304K	Buy	330 +3	+0.9%	+$3.04K	0.03%	123
2025 Q4	$352K	Sell	327 -1	-0.3%	-$956	0.03%	118
2025 Q3	$250K	Sell	328 -9	-3%	-$6.7K	0.03%	137
2025 Q2	$263K	Hold	337	–	–	0.03%	136
2025 Q1	$278K	Sell	337 -69	-17%	-$57.4K	0.03%	126
2024 Q4	$313K	Sell	406 -76	-16%	-$62.9K	0.04%	121
2024 Q3	$427K	Buy	482 +62	+15%	+$55.7K	0.05%	108
2024 Q2	$380K	Sell	420 -41	-9%	-$32.8K	0.05%	112
2024 Q1	$359K	Buy	461 +75	+19%	+$53.4K	0.04%	117
2023 Q4	$225K	Buy	386 +6	+2%	+$3.5K	0.03%	135
2023 Q3	$204K	Buy	+380	New	+$196K	0.03%	139
2021 Q4	–	Sell	-1,014	Closed	-$234K	–	147
2021 Q3	$234K	Buy	+1,014	New	+$250K	0.04%	126

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Global Strategic Investment Solutions's LLY Position: Q2 2026 in Review

Global Strategic Investment Solutions reduced its Eli Lilly (LLY) stake by 0.91% in Q2 2026, selling an estimated $3.06K and leaving 327 shares worth $392K. The position accounts for 0.03% of the portfolio, ranked #115.

Global Strategic Investment Solutions first reported a position in LLY in Q3 2021 and has held it in 13 quarters since. The position peaked at $427K in Q3 2024. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Global Strategic Investment Solutions held 327 shares of Eli Lilly worth $392K as of Q2 2026.
Global Strategic Investment Solutions sold 3 Eli Lilly shares in Q2 2026, an estimated $3.06K.
Eli Lilly made up 0.03% of Global Strategic Investment Solutions's portfolio in Q2 2026, its #115 holding.
Global Strategic Investment Solutions first reported a position in Eli Lilly in Q3 2021 and has held it in 13 quarters since.
Global Strategic Investment Solutions's Eli Lilly position peaked at $427K in Q3 2024.
4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Global Strategic Investment Solutions's 13F filing for Q2 2026, filed 7 Aug 2026.